AAAAAA

   
Results: 1-2 |
Results: 2
Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect - Reduction of MRNA levels for interleukin-1 beta, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor alpha (PPAR alpha) in primary endothelial cells
Authors: Inoue, I Goto, S Mizotani, K Awata, T Mastunaga, T Kawai, S Nakajima, T Hokari, S Komoda, T Katayama, S
Citation: I. Inoue et al., Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect - Reduction of MRNA levels for interleukin-1 beta, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor alpha (PPAR alpha) in primary endothelial cells, LIFE SCI, 67(8), 2000, pp. 863-876
Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: Reduction of mRNA levels for interleukin-1 beta, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor ct (PPAR alpha) in primary endothelial cells (vol 67, pg 863, 2000)
Authors: Inoue, I Goto, S Mizotani, K Awata, T Mastunaga, T Kawai, S Nakajima, T Hokari, S Komoda, T Katayama, S
Citation: I. Inoue et al., Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: Reduction of mRNA levels for interleukin-1 beta, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor ct (PPAR alpha) in primary endothelial cells (vol 67, pg 863, 2000), LIFE SCI, 67(15), 2000, pp. 1919-1919
Risultati: 1-2 |